Researchers are using artificial intelligence to analyze retinal imaging to identify early signs of Alzheimer’s disease before clinical symptoms appear.
This approach could transform dementia care by providing a non-invasive method to screen for risk during routine eye exams. Early detection allows for earlier medical intervention and better planning for patients and families.
In a discussion hosted by Lindsey Seavert, Dr. Oana Dumitrascu of the Mayo Clinic and Dr. Yalin Wang of Arizona State University said the eye serves as a window into the brain. The retina is an extension of the central nervous system, meaning changes in the eye often mirror changes occurring in the brain.
AI algorithms are trained to spot subtle patterns in retinal photographs that are invisible to the human eye. These patterns can indicate the presence of biomarkers associated with Alzheimer's. The study referenced in this research involved tens of thousands of patients [1].
Traditional methods for diagnosing Alzheimer's often involve expensive PET scans or invasive lumbar punctures. Retinal imaging offers a potential alternative that is faster and less stressful for the patient. Dr. Dumitrascu and Dr. Wang said the goal is to integrate this technology into standard healthcare settings.
While the technology is promising, the researchers said these scans identify risk factors rather than providing a definitive diagnosis. The AI identifies signals that suggest a higher probability of developing the disease years in advance. This allows clinicians to monitor high-risk individuals more closely as new treatments emerge.
“The retina is an extension of the central nervous system”
The shift toward ocular biomarkers represents a move toward 'preventative neurology.' By leveraging AI to process massive datasets—such as the tens of thousands of patients in this study—clinicians may eventually move from treating symptomatic dementia to managing a pre-clinical state, potentially extending the window for effective therapeutic intervention.
